𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Improving Patient Retention After Botulinum Toxin Type A Treatment

✍ Scribed by LUCILLE WHITE; ELIZABETH L. TANZI; TINA S. ALSTER

Book ID
109076173
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
64 KB
Volume
32
Category
Article
ISSN
1076-0512

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Botulinum toxin antibody type A titres a
Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy
✍ Dirk Dressler; Hans Bigalke πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 145 KB

## Abstract In some patients, therapy with botulinum toxin type A (BT‐A) becomes ineffective due to formation of antibodies (BT‐A‐AB). The time course of BT‐A‐AB titres after cessation of BT‐A therapy was quantitatively studied to determine whether and when they might drop. Thirteen patients (eight

Frey syndrome : Treatment with type A bo
Frey syndrome : Treatment with type A botulinum toxin
✍ Jens J. von Lindern; Bernd Niederhagen; Stefan BergΓ©; Georg HΓ€gler; Rudolf H. Re πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 448 KB πŸ‘ 1 views

## Background: Frey syndrome was first described by baillarger in 1853. frey provided a detailed analysis and description as "auriculotemporal syndrome" in 1923. according to the literature, even the most recent therapeutic measures described for the treatment of patients with frey syndrome have li